Sitagliptin Malate Enzymatic

CAS 1240039-02-4
Back to the Catalog Contact us about this API

General Information

Sitagliptin is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor used in conjunction with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.

About the API

Technology Synthetic
Therapeutic category Diabetes
Available formulations Oral Solid Oral Solid Long-Acting
Regulations EU DMF Flag EU DMF Korea DMF Flag Korea DMF

Related API products

Pioglitazone HCl 112529-15-4 Semaglutide 910463-68-2 Sitagliptin Phosphate Enzymatic 654671-78-0 Empagliflozin 864070-44-0

The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.

For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.

This site uses cookies (unless you have disabled them) to give you a better and personalized browsing experience and targeted ads.
By continuing your visit on this website, you agree to the use of Cookies on your device. Find out more in our Privacy Policy